Skip to main content

Peer Review reports

From: SGLT2 inhibitor in a type 2 diabetes mellitus patient coexisted with central diabetes insipidus following hyperosmolar hyperglycemic state

Original Submission
29 Aug 2023 Submitted Original manuscript
26 Oct 2024 Reviewed Reviewer Report
28 Oct 2024 Reviewed Reviewer Report - Mathew John
12 Nov 2024 Author responded Author comments - Hui Guo
Resubmission - Version 2
12 Nov 2024 Submitted Manuscript version 2
13 Nov 2024 Author responded Author comments - Hui Guo
Resubmission - Version 3
13 Nov 2024 Submitted Manuscript version 3
14 Nov 2024 Author responded Author comments - Hui Guo
Resubmission - Version 4
14 Nov 2024 Submitted Manuscript version 4
28 Nov 2024 Reviewed Reviewer Report
31 Jan 2025 Reviewed Reviewer Report
17 Feb 2025 Reviewed Reviewer Report
4 Mar 2025 Author responded Author comments - Hui Guo
Resubmission - Version 5
4 Mar 2025 Submitted Manuscript version 5
10 Mar 2025 Reviewed Reviewer Report
11 Mar 2025 Reviewed Reviewer Report
26 Mar 2025 Author responded Author comments - Hui Guo
Resubmission - Version 6
26 Mar 2025 Submitted Manuscript version 6
27 Mar 2025 Author responded Author comments - Hui Guo
Resubmission - Version 7
27 Mar 2025 Submitted Manuscript version 7
Publishing
4 Apr 2025 Editorially accepted
22 Apr 2025 Article published 10.1186/s12902-025-01924-1

You can find further information about peer review here.

Back to article page